By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere said today that it has been granted 510(k) clearance from the US Food and Drug Administration for its Verigene Respiratory Virus Plus Nucleic Acid Test, which runs on the Verigene system.

Nanosphere said that the RV+ test detects influenza A and B and respiratory syncytial virus A and B, and further subtypes flu A as H1, H3, or 2009 H1N1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.